
Werewolf Therapeutics, Inc. (HOWL)
Last updated: 2026-10-21 20:53:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Werewolf Therapeutics, Inc. (HOWL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.02, with a market capitalization of $50.55M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.27 to $1.83. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$50.55M | |
$1.05 | |
$23.99 | |
$0.27 | |
$1.05 | |
198.11K | |
6.89M | |
-- | |
$1.83 | |
$0.27 | |
-- | |
-- |
Werewolf Therapeutics, Inc. (HOWL) After-Hours Stock Price
Werewolf Therapeutics, Inc. (HOWL) is trading at $1.02 in after-hours trading as of 2026-10-21 20:41:00, down 2.86% ($0.03) from the regular-session close of $1.05.
After-hours trading shows how investors are pricing HOWL after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Werewolf Therapeutics, Inc. (HOWL) 7-Day Stock Price Change
Over the past seven days, Werewolf Therapeutics, Inc. (HOWL) moved from $0.98 to $1.02, representing a gain of 3.48% ($0.03).
The stock traded between $0.96 and $1.09 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 490.10 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
HOWL 52-Week Price Position
Position in Range: 47.8%
HOWL is currently trading at $1.02, placing it 47.8% of the way from its 52-week low of $0.27 to its 52-week high of $1.83. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Werewolf Therapeutics, Inc. (HOWL)?
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Werewolf Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Werewolf Therapeutics, Inc. (HOWL) Stock on MEXC
Eligible investors can buy real shares of Werewolf Therapeutics, Inc. (HOWL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Werewolf Therapeutics, Inc. (HOWL) stock price today?
2.Is HOWL stock going up or down today?
3.What is HOWL pre-market price?
4.What is HOWL after-hours price?
5.Is HOWL stock trading now?
6.Where does HOWL sit relative to its 52-week high and low?
7.What sector is Werewolf Therapeutics, Inc. in?
8.What is Werewolf Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is HOWL valued in terms of P/E ratio and EPS?
10.Does Werewolf Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
HOWL Stock Calculator
Estimate the value between HOWL shares and USD.
HOWL Shares to USD
1.00 HOWL shares = 1.016 USD
Calculations are estimates based on the latest available price and are for reference only.



